Thomas Charles Heineman

Insider Reports History

Location
San Diego, CA
Signature
/s/ Kirk Look, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Charles Heineman:

Company Role Class Num Shares Value Price $ Report Date Ownership
ONCOLYTICS BIOTECH INC Chief Medical Officer Common Shares 282,818 $233,890 $0.8270 12 Feb 2026 Direct

Insider Reports Filed by Thomas Charles Heineman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ONCY ONCOLYTICS BIOTECH INC 12 Feb 2026 1 +$10,033 4 Chief Medical Officer 13 Feb 2026, 07:00
ONCY ONCOLYTICS BIOTECH INC 01 Jan 2026 0 $0 3 Chief Medical Officer 02 Jan 2026, 16:30